Welcome!
To use the personalized features of this site, please log in or register.
If you have forgotten your username or password, we can help.
|
 |
Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes
| |
|
Contiguous X-chromosome Deletion Syndrome Encompassing the BTK, TIMM8A, TAF7L, and DRP2 Genes
Anna Šedivá1 , C. I. Edvard Smith2, A. Charlotta Asplund2, Jan Hadač3, Aleš Janda1, Jiří Zeman4, Hana Hansíková4, Lenka Dvořáková4, Lenka Mrázová4, Sirje Velbri5, Carla Koehler6, Karin Roesch6, Kathleen E. Sullivan7, Takeshi Futatani8, 9 and Hans D. Ochs8
| (1) |
Institute of Immunology, University Hospital Motol, V Uvalu 84, 150 06 Prague 5, Czech Republic |
| (2) |
Clinical Research Center, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Huddinge, Sweden |
| (3) |
Department of Neurology, Thomayer Hospital, Prague, Czech Republic |
| (4) |
Centre of Applied Genomics, First Medical Faculty, Charles University, Prague, Czech Republic |
| (5) |
Tallinn Children’s Hospital, Tallinn, Estonia |
| (6) |
Department of Chemistry & Biochemistry, University of California, Los Angeles, USA |
| (7) |
Department of Pediatrics, University of Pennsylvania, Philadelphia, USA |
| (8) |
Department of Pediatrics School of Medicine, University of Washington, Seattle, USA |
| (9) |
Department of Pediatrics, Toyama Medical and Pharmaceutical University, Toyama, Japan |
Received: 24 June 2007 Accepted: 30 July 2007 Published online: 12 September 2007
Abstract X-linked agammaglobulinemia (XLA) is characterized by low levels of B-lymphocytes with early-onset, recurrent, microbial infections
occasionally causing neurological symptoms. We observed an atypical clinical course of XLA, complicated since early childhood
with neurological impairment, progressive sensorineural deafness, and dystonia in six boys of four unrelated families. The
neurologic symptoms suggested the diagnosis of Mohr–Tranebjaerg syndrome, caused by mutations in the TIMM8A gene, previously known as DDP1, and located centromerically of BTK. Deafness dystonia peptide (DDP1) participates in neurological development and is a part of the mitochondrial protein import
pathway. Mutation analysis of the BTK gene revealed gross deletions of different lengths in all patients, in one case extending approximately 196 kb, including
the genes TIMM8A, TAF7L, and DRP2. The most prominent clinical findings of this contiguous deletion syndrome are the combination of immunodeficiency and sensorineural
deafness, which were present in all affected boys. The severity of symptoms, however, did not correlate with the extent of
the deletion.
Keywords X-linked agammaglobulinemia (XLA) - Bruton tyrosine kinase (BTK) - Mohr–Tranebjaerg syndrome - immunodeficiency - sensorineural deafness
Fulltext Preview (Small, Large)
 References secured to subscribers.
|
|
|
|
|
|